Director of Microbiology and Infectious Diseases Molecular Diagnostics at University of Louisville Hospital
BIOGRAPHY
DEC 14, 2022 12:00 PM PST
A Laboratory and Clinical Multi-disciplinary Partnership for the Treatment of Cancer Patients
Speakers
-
Dr. Robert Emmons
Head of the Blood Cancer, Transplant, and Cellular Therapy Division at UofL HealthBIOGRAPHY
Event Date & Time
Date: December 14, 2022
Time: 12:00pm (PST), 3:00pm (EST), 9:00pm (CET)
Abstract
Adopting novel technologies is essential for improving patient outcomes, but the key to sustainable success is through strategic partnerships within the hospital. During this webinar, participants will learn the best practices for implementing innovative diagnostics, like T2 Biosystems sepsis panels, with first-hand experience from the University of Louisville Hospital through the lens of laboratory and clinical departments. Speakers will share their experiences collaboratively deciding on patient selection criteria, acting on diagnostic results, and educating clinicians on new technologies to meet operational and care-oriented goals. They will also present real-world clinical case studies from the bone marrow transplant population demonstrating the benefits of rapid diagnostics for patients in need.
Learning Objectives
- Review a successful experience of implementing T2 Biosystems' diagnostics in the hospital laboratory and the positive impact on operational and clinical outcomes
- Outline best practices for hospital partnerships in implementing new technologies
- Demonstrate the clinical utility of T2 Biosystems sepsis panels for cancer and bone marrow transplant populations through real-world case studies
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...